How big Pharma’s Lust for Profit Harms Their Customers

0
336

From AlterNet: The increasing pace at which the FDA is approving new drugs can lead to significant risks to patient safety. Drugs that once would have been rejected by regulators due to alarming levels of risk are increasingly being fast-tracked or expedited for approval.

Article →­

LEAVE A REPLY